-
BIOTECH Careers EXPLAINED: 10 HIGH $$ Jobs to explore 🌱
[ Please watch in HD ]
Hello my loves! 💜
Hope you are all having a great week! Today Im back with another career related video! Lately Ive been getting lots of dms with questions regarding the biotech/life science industry so I decided to make a video to address some of the common questions/concerns I get. Hope you enjoy!
Love always,
Rice
PS. The purpose of this video is to provide you all with some more info about MY understanding of the life science industry. Pls keep in mind I dont know everything. Just trying to help some people out with the limited knowledge I do have 💜
A big thank you to Yesstyle & Nail Reserve for sending me some products to try!
Use [RICEXNR] for 50% off when you purchase 2 or more gel polishes!
https://bit.ly/NailReserve_RICEXNR
Yesstyle: use RICEZHANGG12...
published: 24 Jun 2023
-
What It Takes To Build A $4.8 Billion Biotech Company | Forbes
For the launch of this year’s Next Billion Dollar Startup list, we wanted to go back to the companies that successfully climbed to the ranks of unicorn and ask their leaders: what have you learned.
Jason Kelly is CEO and cofounder of Ginkgo Bioworks, a biotech company and 2019 member of the Next Billion Dollar Startup list. Kelly spoke about the unique challenges raising capital in an environment that’s not used to dealing with technical risk. He also spoke about the missteps young entrepreneurs take when approaching venture capital funding.
Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1
Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forb...
published: 12 Jun 2020
-
We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the state of the biotech industry, impact of interest rate environment on the sector, growth outlook in 2024, obesity drug market, and more.
published: 15 Dec 2023
-
The Biotech Lesson You Forgot
Too many new traders don’t know the most important rule about trading sketchy biotech stocks. There can be great trading opportunities with these stocks, but only if you know the RULES. What’s the essential lesson for biotech stocks? Tune in as Tim Bohen breaks it down.
🔴 Ready to learn more? Check out the SteadyTrade Team: https://stockstotrade.info/3xGDhwG
🔴 Try StocksToTrade for $7: https://stockstotrade.info/3xEFhWr
🚀 Check out Small Cap Rockets: https://stockstotrade.com/small-cap-rockets/
📲 Download the STT app for iOS: https://apps.apple.com/us/app/stockstotrade-mobile/id1403963724
📲 Download the STT app for Android: https://play.google.com/store/apps/details?id=com.stockstotrade
🔴 Subscribe for more free Stock Trading tips: YouTube.com/StocksToTrade
👉Share this video with ...
published: 11 Aug 2021
-
FIVE 6-FIGURE BIOTECH CAREERS nobody talks about.
Join 2300+ academics who receive my weekly newsletter: https://theboldphd.com/careerslist
Get my 90-minute course on becoming a medical writer: https://theboldphd.com/learn/
Build a personal brand on LinkedIn with this course: https://theboldphd.com/learn/
5 BIOTECH CAREERS you probably didn't know about
More videos for you to watch:
This PhD left her TENURED professor position because of THIS: https://youtu.be/M5_ZwBxCkIA
How This Communications PhD landed a role as a UX Researcher at Meta: https://youtu.be/MrtlJBF1TX0
This Humanities PhD turned his degree into a career in tech: https://youtu.be/KG8odaU_J5g
How Dr. Vera Chan got started with regulatory medical writing: https://youtu.be/m3sE042IhOk
Let's connect on LinkedIn - https://www.linkedin.com/in/geenonterah/
#phds #phdcareer...
published: 25 Jul 2022
-
How China May Soon Lead the Bio-Revolution
Beijing has poured billions of dollars into biotechnology as the sector undergoes a momentous expansion. AI, gene editing and synthetic biology may be the cornerstones of the next great industrial revolution, and China may lead it.
#China2030 #BloombergQuicktake #Biotech
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join
Subscribe to Quicktake Explained: https://bit.ly/3iERrup
QuickTake Originals is Bloomberg's official premium video channel. We bring you insights and analysis from business, science, and technology experts who are shaping our future. We’re home to Hello World, Giant Leap, Storylines, and the series powering CityLab, Bloomberg Businessweek, Bloomberg...
published: 29 Mar 2022
-
There's a crop of great biotech companies ready to be acquired, says MPM's Christiana Bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition risk in pharmaceuticals. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: htt...
published: 02 Feb 2023
-
Breaking Down Biotech Innovations with Dr. Bob Langer
Today’s guest is MIT professor, chemical engineer, scientist, inventor, and investor Dr. Bob Langer. Dr. Langer has over 1,400 granted or pending patents and has been cited 374,000 times (and counting)! As a co-founder of Moderna, he has great insights into the potential of mRNA to treat diseases of various descriptions. Joining us to pick this extraordinary mind is clinically trained entrepreneur, Dr. Charlie Roberts. In this conversation, we discuss emerging biotechnologies, the potential of artificial intelligence (AI) in this space, as well as what might be attributed to the current downturn of the market. Dr. Langer lists potential time-to-market accelerators for new therapies and vaccines and shares his advice for those looking to make an impact from an academic and/or entrepreneuria...
published: 31 Oct 2022
-
What is biotechnology? It's where science meets entrepreneurship
Biotechnology is the perfect blend of science and business. When you study biotechnology at UQ you'll learn about the scientific, business and legal requirements needed to take an idea from concept to market.
published: 13 Aug 2019
-
How to Trade Recent BioTechs
🔥 High Odds Summit sign up: https://stevenduxi.thinkific.com/pages/hotsummit
⚡ Traders Edge Course: https://stevenduxi.thinkific.com/pages/TradersEdge
😎 Join Freedom Challenge: https://www.stevenduxi.com/freedom-challenge/
⚡Stock Craft Course: https://stevenduxi.thinkific.com/courses/stockcrafteducation
💬 Join our Free Discord Room Click ► https://discord.com/invite/q3BGJHs
/////////////////////////////////
In this recent market, we have seen the uptick of Biotech stocks. Trading Biotech stocks can be profitable, but also can be very risky. In this video Dux talks about some things he looks for in trading in this type of market. The pros and cons of Biotech stocks.
A biostock is a type of stock that represents a company involved in the development and commercialization of biotechnol...
published: 24 Jan 2023
7:20
BIOTECH Careers EXPLAINED: 10 HIGH $$ Jobs to explore 🌱
[ Please watch in HD ]
Hello my loves! 💜
Hope you are all having a great week! Today Im back with another career related video! Lately Ive been getting lots o...
[ Please watch in HD ]
Hello my loves! 💜
Hope you are all having a great week! Today Im back with another career related video! Lately Ive been getting lots of dms with questions regarding the biotech/life science industry so I decided to make a video to address some of the common questions/concerns I get. Hope you enjoy!
Love always,
Rice
PS. The purpose of this video is to provide you all with some more info about MY understanding of the life science industry. Pls keep in mind I dont know everything. Just trying to help some people out with the limited knowledge I do have 💜
A big thank you to Yesstyle & Nail Reserve for sending me some products to try!
Use [RICEXNR] for 50% off when you purchase 2 or more gel polishes!
https://bit.ly/NailReserve_RICEXNR
Yesstyle: use RICEZHANGG12 for a discount!
- White Open Back Top (S): https://www.yesstyle.com/en/sosana-plain-open-back-crop-tank-top-black-m/info.html/pid.1118459051
- Freesia Hair Mask: https://ystyle.co/g3S4
- Vitamin C Serum: https://ystyle.co/h2UX
- Black Skirt (S): https://ystyle.co/HUdJ
- White Off the Shoulder Top (S): https://ystyle.co/rvvQ
- White Strapy Top (S): https://ystyle.co/hhh1
- Atobarrier Soothing Cream: https://www.yesstyle.com/en/aestura-ato-barrier-365-hydro-soothing-cream-60ml/info.html/pid.1114910080
🥭
instagram https://www.instagram.com/ricezhangg/
filmed on my iPhone 14 Pro Max/Sony ZV-1 & edited on my phone via vllo
Email: ricezhang888@gmail.com
https://wn.com/Biotech_Careers_Explained_10_High_Jobs_To_Explore_🌱
[ Please watch in HD ]
Hello my loves! 💜
Hope you are all having a great week! Today Im back with another career related video! Lately Ive been getting lots of dms with questions regarding the biotech/life science industry so I decided to make a video to address some of the common questions/concerns I get. Hope you enjoy!
Love always,
Rice
PS. The purpose of this video is to provide you all with some more info about MY understanding of the life science industry. Pls keep in mind I dont know everything. Just trying to help some people out with the limited knowledge I do have 💜
A big thank you to Yesstyle & Nail Reserve for sending me some products to try!
Use [RICEXNR] for 50% off when you purchase 2 or more gel polishes!
https://bit.ly/NailReserve_RICEXNR
Yesstyle: use RICEZHANGG12 for a discount!
- White Open Back Top (S): https://www.yesstyle.com/en/sosana-plain-open-back-crop-tank-top-black-m/info.html/pid.1118459051
- Freesia Hair Mask: https://ystyle.co/g3S4
- Vitamin C Serum: https://ystyle.co/h2UX
- Black Skirt (S): https://ystyle.co/HUdJ
- White Off the Shoulder Top (S): https://ystyle.co/rvvQ
- White Strapy Top (S): https://ystyle.co/hhh1
- Atobarrier Soothing Cream: https://www.yesstyle.com/en/aestura-ato-barrier-365-hydro-soothing-cream-60ml/info.html/pid.1114910080
🥭
instagram https://www.instagram.com/ricezhangg/
filmed on my iPhone 14 Pro Max/Sony ZV-1 & edited on my phone via vllo
Email: ricezhang888@gmail.com
- published: 24 Jun 2023
- views: 54188
2:55
What It Takes To Build A $4.8 Billion Biotech Company | Forbes
For the launch of this year’s Next Billion Dollar Startup list, we wanted to go back to the companies that successfully climbed to the ranks of unicorn and ask ...
For the launch of this year’s Next Billion Dollar Startup list, we wanted to go back to the companies that successfully climbed to the ranks of unicorn and ask their leaders: what have you learned.
Jason Kelly is CEO and cofounder of Ginkgo Bioworks, a biotech company and 2019 member of the Next Billion Dollar Startup list. Kelly spoke about the unique challenges raising capital in an environment that’s not used to dealing with technical risk. He also spoke about the missteps young entrepreneurs take when approaching venture capital funding.
Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1
Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
https://wn.com/What_It_Takes_To_Build_A_4.8_Billion_Biotech_Company_|_Forbes
For the launch of this year’s Next Billion Dollar Startup list, we wanted to go back to the companies that successfully climbed to the ranks of unicorn and ask their leaders: what have you learned.
Jason Kelly is CEO and cofounder of Ginkgo Bioworks, a biotech company and 2019 member of the Next Billion Dollar Startup list. Kelly spoke about the unique challenges raising capital in an environment that’s not used to dealing with technical risk. He also spoke about the missteps young entrepreneurs take when approaching venture capital funding.
Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1
Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
- published: 12 Jun 2020
- views: 54512
5:58
We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the state of the biotech industry, impact of interest rate environment on the secto...
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the state of the biotech industry, impact of interest rate environment on the sector, growth outlook in 2024, obesity drug market, and more.
https://wn.com/We_See_Big_Pharma_Going_After_Smaller_Biotechs_In_2024,_Says_Jefferies'_Michael_Yee
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the state of the biotech industry, impact of interest rate environment on the sector, growth outlook in 2024, obesity drug market, and more.
- published: 15 Dec 2023
- views: 5818
8:59
The Biotech Lesson You Forgot
Too many new traders don’t know the most important rule about trading sketchy biotech stocks. There can be great trading opportunities with these stocks, but on...
Too many new traders don’t know the most important rule about trading sketchy biotech stocks. There can be great trading opportunities with these stocks, but only if you know the RULES. What’s the essential lesson for biotech stocks? Tune in as Tim Bohen breaks it down.
🔴 Ready to learn more? Check out the SteadyTrade Team: https://stockstotrade.info/3xGDhwG
🔴 Try StocksToTrade for $7: https://stockstotrade.info/3xEFhWr
🚀 Check out Small Cap Rockets: https://stockstotrade.com/small-cap-rockets/
📲 Download the STT app for iOS: https://apps.apple.com/us/app/stockstotrade-mobile/id1403963724
📲 Download the STT app for Android: https://play.google.com/store/apps/details?id=com.stockstotrade
🔴 Subscribe for more free Stock Trading tips: YouTube.com/StocksToTrade
👉Share this video with a fellow Trader: https://youtu.be/M2lQr9S9Nb0
✅ Links we mention and recommend:
🔴Try StocksToTrade for $7: https://stockstotrade.info/3xEFhWr
🔴Get our FREE weekly watchlist here: https://stockstotrade.info/2VCzgN3
🔴Traders Blueprint Free Guide: https://stockstotrade.info/37wtSgv
🔴Check out the SteadyTrade Podcast: https://steadytrade.com
🔴FREE StocksToTrade Market Grind: https://lp.stockstotrade.com/market-grind/
✅ Recommended playlists:
🔴SteadyTrade Podcast: http://bit.ly/2SXbrv7
🔴Stock Trading 101: A Day Trader's Guide: http://bit.ly/2sqs1ZZ
🔴Advanced Stock Trading Tips: http://bit.ly/3a32pTM
🔴Trader Spotlight with Tim Bohen: http://bit.ly/36TTzG3
🔴StocksToTrade Software Tips and Tricks: http://bit.ly/375GSry
🔴Weekly Trading Recap Videos: http://bit.ly/3a32uXA
🔴Charts and Patterns: http://bit.ly/2uj2KBO
✅ Follow StocksToTrade on social media:
Instagram: https://www.instagram.com/stockstotrade/
Facebook: https://www.facebook.com/StocksToTrade/
Twitter: https://twitter.com/StocksToTrade
Recently, in a SteadyTrade Team webinar, a student asked if there was potential to hold Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) overnight…
The short answer: NO.
The slightly longer answer: NEVER.
Why? Bohen covers all the deets in the video — so don’t miss it! Here’s a quick preview…
Biotechs typically burn millions of dollars trying to develop a breakthrough drug. With a negative cash flow, it’s difficult to get a loan.
So they go to the public markets — where there’s an endless supply of bag holders who believe the ‘dream.’
Tune in to learn what these companies do when they hit the public markets.
Now these stocks can have momentum, crazy volume, maybe even a press release … But that’s exactly what makes them great for day trading. ✨
Any trader who gets burned by these stocks could end up feeling like the stock market’s all just a scam. But it’s not at all a scam — if you know how to play by the rules!
Tune in and learn this KEY lesson now, particularly for day trading biotechs. Bohen helps you understand the importance of quick entries and exits, key levels, patterns, and more…
And tune in to learn what you should never do when trading biotechs.
#StockMarket #Trading #Biotechs
----------------------------------------------------------------------------------------------------------------
*Tim Bohen teaches skills others have used to make money. Most who receive free or paid content will make little or no money because they will not apply the skills being taught. Any results displayed may be exceptional. We do not guarantee any outcome regarding your earnings or income as the factors that impact such results are numerous and uncontrollable.
You can lose money trading stocks. Do not invest money you cannot afford to lose. You understand and agree you will consider the important risk factors in deciding to purchase any of our products or services.
https://wn.com/The_Biotech_Lesson_You_Forgot
Too many new traders don’t know the most important rule about trading sketchy biotech stocks. There can be great trading opportunities with these stocks, but only if you know the RULES. What’s the essential lesson for biotech stocks? Tune in as Tim Bohen breaks it down.
🔴 Ready to learn more? Check out the SteadyTrade Team: https://stockstotrade.info/3xGDhwG
🔴 Try StocksToTrade for $7: https://stockstotrade.info/3xEFhWr
🚀 Check out Small Cap Rockets: https://stockstotrade.com/small-cap-rockets/
📲 Download the STT app for iOS: https://apps.apple.com/us/app/stockstotrade-mobile/id1403963724
📲 Download the STT app for Android: https://play.google.com/store/apps/details?id=com.stockstotrade
🔴 Subscribe for more free Stock Trading tips: YouTube.com/StocksToTrade
👉Share this video with a fellow Trader: https://youtu.be/M2lQr9S9Nb0
✅ Links we mention and recommend:
🔴Try StocksToTrade for $7: https://stockstotrade.info/3xEFhWr
🔴Get our FREE weekly watchlist here: https://stockstotrade.info/2VCzgN3
🔴Traders Blueprint Free Guide: https://stockstotrade.info/37wtSgv
🔴Check out the SteadyTrade Podcast: https://steadytrade.com
🔴FREE StocksToTrade Market Grind: https://lp.stockstotrade.com/market-grind/
✅ Recommended playlists:
🔴SteadyTrade Podcast: http://bit.ly/2SXbrv7
🔴Stock Trading 101: A Day Trader's Guide: http://bit.ly/2sqs1ZZ
🔴Advanced Stock Trading Tips: http://bit.ly/3a32pTM
🔴Trader Spotlight with Tim Bohen: http://bit.ly/36TTzG3
🔴StocksToTrade Software Tips and Tricks: http://bit.ly/375GSry
🔴Weekly Trading Recap Videos: http://bit.ly/3a32uXA
🔴Charts and Patterns: http://bit.ly/2uj2KBO
✅ Follow StocksToTrade on social media:
Instagram: https://www.instagram.com/stockstotrade/
Facebook: https://www.facebook.com/StocksToTrade/
Twitter: https://twitter.com/StocksToTrade
Recently, in a SteadyTrade Team webinar, a student asked if there was potential to hold Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) overnight…
The short answer: NO.
The slightly longer answer: NEVER.
Why? Bohen covers all the deets in the video — so don’t miss it! Here’s a quick preview…
Biotechs typically burn millions of dollars trying to develop a breakthrough drug. With a negative cash flow, it’s difficult to get a loan.
So they go to the public markets — where there’s an endless supply of bag holders who believe the ‘dream.’
Tune in to learn what these companies do when they hit the public markets.
Now these stocks can have momentum, crazy volume, maybe even a press release … But that’s exactly what makes them great for day trading. ✨
Any trader who gets burned by these stocks could end up feeling like the stock market’s all just a scam. But it’s not at all a scam — if you know how to play by the rules!
Tune in and learn this KEY lesson now, particularly for day trading biotechs. Bohen helps you understand the importance of quick entries and exits, key levels, patterns, and more…
And tune in to learn what you should never do when trading biotechs.
#StockMarket #Trading #Biotechs
----------------------------------------------------------------------------------------------------------------
*Tim Bohen teaches skills others have used to make money. Most who receive free or paid content will make little or no money because they will not apply the skills being taught. Any results displayed may be exceptional. We do not guarantee any outcome regarding your earnings or income as the factors that impact such results are numerous and uncontrollable.
You can lose money trading stocks. Do not invest money you cannot afford to lose. You understand and agree you will consider the important risk factors in deciding to purchase any of our products or services.
- published: 11 Aug 2021
- views: 4179
8:32
FIVE 6-FIGURE BIOTECH CAREERS nobody talks about.
Join 2300+ academics who receive my weekly newsletter: https://theboldphd.com/careerslist
Get my 90-minute course on becoming a medical writer: https://theboldp...
Join 2300+ academics who receive my weekly newsletter: https://theboldphd.com/careerslist
Get my 90-minute course on becoming a medical writer: https://theboldphd.com/learn/
Build a personal brand on LinkedIn with this course: https://theboldphd.com/learn/
5 BIOTECH CAREERS you probably didn't know about
More videos for you to watch:
This PhD left her TENURED professor position because of THIS: https://youtu.be/M5_ZwBxCkIA
How This Communications PhD landed a role as a UX Researcher at Meta: https://youtu.be/MrtlJBF1TX0
This Humanities PhD turned his degree into a career in tech: https://youtu.be/KG8odaU_J5g
How Dr. Vera Chan got started with regulatory medical writing: https://youtu.be/m3sE042IhOk
Let's connect on LinkedIn - https://www.linkedin.com/in/geenonterah/
#phds #phdcareers #theboldphd
Let's connect on LinkedIn - https://www.linkedin.com/in/geenonterah/
https://wn.com/Five_6_Figure_Biotech_Careers_Nobody_Talks_About.
Join 2300+ academics who receive my weekly newsletter: https://theboldphd.com/careerslist
Get my 90-minute course on becoming a medical writer: https://theboldphd.com/learn/
Build a personal brand on LinkedIn with this course: https://theboldphd.com/learn/
5 BIOTECH CAREERS you probably didn't know about
More videos for you to watch:
This PhD left her TENURED professor position because of THIS: https://youtu.be/M5_ZwBxCkIA
How This Communications PhD landed a role as a UX Researcher at Meta: https://youtu.be/MrtlJBF1TX0
This Humanities PhD turned his degree into a career in tech: https://youtu.be/KG8odaU_J5g
How Dr. Vera Chan got started with regulatory medical writing: https://youtu.be/m3sE042IhOk
Let's connect on LinkedIn - https://www.linkedin.com/in/geenonterah/
#phds #phdcareers #theboldphd
Let's connect on LinkedIn - https://www.linkedin.com/in/geenonterah/
- published: 25 Jul 2022
- views: 16153
24:10
How China May Soon Lead the Bio-Revolution
Beijing has poured billions of dollars into biotechnology as the sector undergoes a momentous expansion. AI, gene editing and synthetic biology may be the corne...
Beijing has poured billions of dollars into biotechnology as the sector undergoes a momentous expansion. AI, gene editing and synthetic biology may be the cornerstones of the next great industrial revolution, and China may lead it.
#China2030 #BloombergQuicktake #Biotech
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join
Subscribe to Quicktake Explained: https://bit.ly/3iERrup
QuickTake Originals is Bloomberg's official premium video channel. We bring you insights and analysis from business, science, and technology experts who are shaping our future. We’re home to Hello World, Giant Leap, Storylines, and the series powering CityLab, Bloomberg Businessweek, Bloomberg Green, and much more.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel QuickTake News for breaking global news and insight in an instant.
https://wn.com/How_China_May_Soon_Lead_The_Bio_Revolution
Beijing has poured billions of dollars into biotechnology as the sector undergoes a momentous expansion. AI, gene editing and synthetic biology may be the cornerstones of the next great industrial revolution, and China may lead it.
#China2030 #BloombergQuicktake #Biotech
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join
Subscribe to Quicktake Explained: https://bit.ly/3iERrup
QuickTake Originals is Bloomberg's official premium video channel. We bring you insights and analysis from business, science, and technology experts who are shaping our future. We’re home to Hello World, Giant Leap, Storylines, and the series powering CityLab, Bloomberg Businessweek, Bloomberg Green, and much more.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel QuickTake News for breaking global news and insight in an instant.
- published: 29 Mar 2022
- views: 600147
4:46
There's a crop of great biotech companies ready to be acquired, says MPM's Christiana Bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innov...
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition risk in pharmaceuticals. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
https://wn.com/There's_A_Crop_Of_Great_Biotech_Companies_Ready_To_Be_Acquired,_Says_Mpm's_Christiana_Bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition risk in pharmaceuticals. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
- published: 02 Feb 2023
- views: 10811
31:34
Breaking Down Biotech Innovations with Dr. Bob Langer
Today’s guest is MIT professor, chemical engineer, scientist, inventor, and investor Dr. Bob Langer. Dr. Langer has over 1,400 granted or pending patents and ha...
Today’s guest is MIT professor, chemical engineer, scientist, inventor, and investor Dr. Bob Langer. Dr. Langer has over 1,400 granted or pending patents and has been cited 374,000 times (and counting)! As a co-founder of Moderna, he has great insights into the potential of mRNA to treat diseases of various descriptions. Joining us to pick this extraordinary mind is clinically trained entrepreneur, Dr. Charlie Roberts. In this conversation, we discuss emerging biotechnologies, the potential of artificial intelligence (AI) in this space, as well as what might be attributed to the current downturn of the market. Dr. Langer lists potential time-to-market accelerators for new therapies and vaccines and shares his advice for those looking to make an impact from an academic and/or entrepreneurial standpoint. Tune in to hear more about the innovations Dr. Langer has been involved in over the years, and what we can look forward to in the future!
Key Points From This Episode:
- Dr. Bob Langer highlights his favorite patent.
- Dr. Langer’s career achievements.
- Some factors impacting the current biotech market downturn.
- The correlation between magic and science.
- What mRNA is and why it’s an ideal candidate for treating disease.
- The personalized cancer vaccines Merck and Moderna are currently developing.
- Under what circumstances mRNA isn’t the solution.
- The emerging biotechnologies Dr. Langer is most excited about.
- The applications of organs on a chip.
- The potential of AI in the biotech space.
- Potential time-to-market accelerators for new therapies and vaccines.
- How to make an impact in the academic and entrepreneurial biotech spaces.
- The importance of understanding intellectual property.
- The team aspect of innovation.
- Dr. Langer’s tales of perseverance.
- Strategies for enforcing IPs.
- Dr. Langer’s delivery expertise.
- How he’s balanced his work and family life over the years.
More FYI Podcasts: https://ark-invest.com/podcasts/
To learn more about ARK: https://ark-invest.com/
For more updates, follow us on:
Twitter: https://arkinv.st/3corDiY
LinkedIn: http://arkinv.st/1f7AiVX
Facebook: http://arkinv.st/3r4EDOU
Instagram: http://arkinv.st/39td8bO
Disclosure: http://arkinv.st/39rzF94More FYI Podcasts: https://ark-invest.com/podcasts/
https://wn.com/Breaking_Down_Biotech_Innovations_With_Dr._Bob_Langer
Today’s guest is MIT professor, chemical engineer, scientist, inventor, and investor Dr. Bob Langer. Dr. Langer has over 1,400 granted or pending patents and has been cited 374,000 times (and counting)! As a co-founder of Moderna, he has great insights into the potential of mRNA to treat diseases of various descriptions. Joining us to pick this extraordinary mind is clinically trained entrepreneur, Dr. Charlie Roberts. In this conversation, we discuss emerging biotechnologies, the potential of artificial intelligence (AI) in this space, as well as what might be attributed to the current downturn of the market. Dr. Langer lists potential time-to-market accelerators for new therapies and vaccines and shares his advice for those looking to make an impact from an academic and/or entrepreneurial standpoint. Tune in to hear more about the innovations Dr. Langer has been involved in over the years, and what we can look forward to in the future!
Key Points From This Episode:
- Dr. Bob Langer highlights his favorite patent.
- Dr. Langer’s career achievements.
- Some factors impacting the current biotech market downturn.
- The correlation between magic and science.
- What mRNA is and why it’s an ideal candidate for treating disease.
- The personalized cancer vaccines Merck and Moderna are currently developing.
- Under what circumstances mRNA isn’t the solution.
- The emerging biotechnologies Dr. Langer is most excited about.
- The applications of organs on a chip.
- The potential of AI in the biotech space.
- Potential time-to-market accelerators for new therapies and vaccines.
- How to make an impact in the academic and entrepreneurial biotech spaces.
- The importance of understanding intellectual property.
- The team aspect of innovation.
- Dr. Langer’s tales of perseverance.
- Strategies for enforcing IPs.
- Dr. Langer’s delivery expertise.
- How he’s balanced his work and family life over the years.
More FYI Podcasts: https://ark-invest.com/podcasts/
To learn more about ARK: https://ark-invest.com/
For more updates, follow us on:
Twitter: https://arkinv.st/3corDiY
LinkedIn: http://arkinv.st/1f7AiVX
Facebook: http://arkinv.st/3r4EDOU
Instagram: http://arkinv.st/39td8bO
Disclosure: http://arkinv.st/39rzF94More FYI Podcasts: https://ark-invest.com/podcasts/
- published: 31 Oct 2022
- views: 6982
1:39
What is biotechnology? It's where science meets entrepreneurship
Biotechnology is the perfect blend of science and business. When you study biotechnology at UQ you'll learn about the scientific, business and legal requirement...
Biotechnology is the perfect blend of science and business. When you study biotechnology at UQ you'll learn about the scientific, business and legal requirements needed to take an idea from concept to market.
https://wn.com/What_Is_Biotechnology_It's_Where_Science_Meets_Entrepreneurship
Biotechnology is the perfect blend of science and business. When you study biotechnology at UQ you'll learn about the scientific, business and legal requirements needed to take an idea from concept to market.
- published: 13 Aug 2019
- views: 7756
4:46
How to Trade Recent BioTechs
🔥 High Odds Summit sign up: https://stevenduxi.thinkific.com/pages/hotsummit
⚡ Traders Edge Course: https://stevenduxi.thinkific.com/pages/TradersEdge
😎 Join Fr...
🔥 High Odds Summit sign up: https://stevenduxi.thinkific.com/pages/hotsummit
⚡ Traders Edge Course: https://stevenduxi.thinkific.com/pages/TradersEdge
😎 Join Freedom Challenge: https://www.stevenduxi.com/freedom-challenge/
⚡Stock Craft Course: https://stevenduxi.thinkific.com/courses/stockcrafteducation
💬 Join our Free Discord Room Click ► https://discord.com/invite/q3BGJHs
/////////////////////////////////
In this recent market, we have seen the uptick of Biotech stocks. Trading Biotech stocks can be profitable, but also can be very risky. In this video Dux talks about some things he looks for in trading in this type of market. The pros and cons of Biotech stocks.
A biostock is a type of stock that represents a company involved in the development and commercialization of biotechnology products and services. These companies typically focus on research and development in areas such as genetic engineering, genomics, and drug discovery. Biotechnology companies can be involved in the development of drugs, medical devices, and diagnostic tools, as well as in agriculture, biofuels, and other areas. Biostocks can be listed on a stock exchange, traded in OTC markets, and can be considered as high-risk high-reward investments as the development and commercialization of biotechnology products and services take long time and a lot of resources.
////////////////////////////////
📲 My Only Official Social Media Accounts: https://linktr.ee/Duxtrading
We do not have any other social media accounts.
////////////////////////////////
📝 Sign up for our free Stock Craft class https://stevenduxi.thinkific.com/courses/stockcrafteducation
// Disclaimer: https://www.stevenduxi.com/disclaimer/
// Contact Us: https://www.stevenduxi.com/contact-us/
#Pennystockmillionaire #learntotrade #stocks #market #trading #daytrading #howtomakemoneyonline #business #finviz #stevenduxi #stevendux #stockcraft #tradersedge #dux #stevenduxtradingstrategies #TheDuxinator #tradersedge #highoddsradingsummit #biotechstocks
https://wn.com/How_To_Trade_Recent_Biotechs
🔥 High Odds Summit sign up: https://stevenduxi.thinkific.com/pages/hotsummit
⚡ Traders Edge Course: https://stevenduxi.thinkific.com/pages/TradersEdge
😎 Join Freedom Challenge: https://www.stevenduxi.com/freedom-challenge/
⚡Stock Craft Course: https://stevenduxi.thinkific.com/courses/stockcrafteducation
💬 Join our Free Discord Room Click ► https://discord.com/invite/q3BGJHs
/////////////////////////////////
In this recent market, we have seen the uptick of Biotech stocks. Trading Biotech stocks can be profitable, but also can be very risky. In this video Dux talks about some things he looks for in trading in this type of market. The pros and cons of Biotech stocks.
A biostock is a type of stock that represents a company involved in the development and commercialization of biotechnology products and services. These companies typically focus on research and development in areas such as genetic engineering, genomics, and drug discovery. Biotechnology companies can be involved in the development of drugs, medical devices, and diagnostic tools, as well as in agriculture, biofuels, and other areas. Biostocks can be listed on a stock exchange, traded in OTC markets, and can be considered as high-risk high-reward investments as the development and commercialization of biotechnology products and services take long time and a lot of resources.
////////////////////////////////
📲 My Only Official Social Media Accounts: https://linktr.ee/Duxtrading
We do not have any other social media accounts.
////////////////////////////////
📝 Sign up for our free Stock Craft class https://stevenduxi.thinkific.com/courses/stockcrafteducation
// Disclaimer: https://www.stevenduxi.com/disclaimer/
// Contact Us: https://www.stevenduxi.com/contact-us/
#Pennystockmillionaire #learntotrade #stocks #market #trading #daytrading #howtomakemoneyonline #business #finviz #stevenduxi #stevendux #stockcraft #tradersedge #dux #stevenduxtradingstrategies #TheDuxinator #tradersedge #highoddsradingsummit #biotechstocks
- published: 24 Jan 2023
- views: 4279